Drugs and Cell Therapies in Hematology

The aim of this journal is to publish peer-reviewed papers on different issues of experimental and clinical hematology preferentially dealing with, though not limited to, experimental, pre-clinical and clinical studies with conventional and novel drugs and cell-based therapies in hematology.

Articles should be below 25% plagiarized including references.

Average time (submission to publication) – 30-45 days

Indexed link: https://mjl.clarivate.com/search-results